Gene dose effects of GSTM1, GSTT1 and GSTP1 polymorphisms on outcome in childhood acute lymphoblastic leukemia

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 1, 2012, Pages 38-42

  Borst, Louise ^a   Buchard, Anders ^b   Rosthøj, Susanne ^c   Wesolowska, Agata ^d   Wehner, Peder Skov ^e   Wesenberg, Finn ^f   Dalhoff, Kim ^g   Schmiegelow, Kjeld ^a,c  

^a University of Copenhagen   (Denmark)

^b Faculty of Health Sciences   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g BISPEBJERG HOSPITAL   (Denmark)

Author keywords

childhood acute lymphoblastic leukemia; gene dose effect; genetic polymorphism; glutathione S transferase; outcome

Indexed keywords

GLUTATHIONE TRANSFERASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER RELAPSE; CANCER RESISTANCE; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DNA POLYMORPHISM; EVENT FREE SURVIVAL; FEMALE; GENE DOSAGE; GENETIC VARIABILITY; GENOTYPE; GSTM1 GENE; GSTP1 GENE; GSTT1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TUMOR GENE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE DOSAGE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; INFANT; MALE; POLYMORPHISM, GENETIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84855451686     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182346cdd     Document Type: Article

References (28)

1. Hjalgrim LL, Rostgaard K, Schmiegelow K, et al. Age- and sex-specific incidence of childhood leukemia by immunophe-notype in the Nordic countries. J Natl Cancer Inst. 2003; 95:1539-1544. (Pubitemid 37322097)
2. Schmiegelow K, Forestier E, Hellebostad M, et al. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia. 2010;24: 345-354.
3. Schmiegelow K, Al-Modhwahi I, Andersen MK, et al. Methotrexate/6- mercaptopurine maintenance therapy influences the risk of a second malignant neoplasm after childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study. Blood. 2009;113:6077-6084.
4. Lund B, Asberg A, Heyman M, et al. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia. Pediatr Blood Cancer. 2011;56:551-559.
5. Davidsen ML, Dalhoff K, Schmiegelow K. Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2008;30:831-849.
6. Borst L, Wallerek S, Dalhoff K, et al. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia. Eur J Haematol. 2011;86:477-483.
7. Townsend DM, Tew KD. The role of glutathione-S-transfer-ase in anti-cancer drug resistance. Oncogene. 2003;22: 7369-7375.
8. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 1994;54:4313-4320. (Pubitemid 24273141)
9. Bosch TM, Meijerman I, Beijnen JH, et al. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer. Clin Pharmacokinet. 2006;45:253-285. (Pubitemid 43327492)
10. Ali-Osman F, Akande O, Antoun G, et al. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem. 1997;272:10004-10012. (Pubitemid 27171673)
11. Seidegard J, Vorachek WR, Pero RW, et al. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A. 1988;85:7293-7297.
12. Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300(Pt 1):271-276. (Pubitemid 24151046)
13. Stanulla M, Schrappe M, Brechlin AM, et al. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Blood. 2000;95:1222-1228. (Pubitemid 30099830)
14. Anderer G, Schrappe M, Brechlin AM, et al. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia. Pharmacogenetics. 2000;10:715-726.
15. Meissner B, Stanulla M, Ludwig WD, et al. The GSTT1 deletion polymorphism is associated with initial response to glucocorticoids in childhood acute lymphoblastic leukemia. Leukemia. 2004;18:1920-1923. (Pubitemid 39530030)
16. Rocha JC, Cheng C, Liu W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005;105:4752-4758. (Pubitemid 40807300)
17. Kishi S, Cheng C, French D, et al. Ancestry and pharmaco-genetics of antileukemic drug toxicity. Blood. 2007;109: 4151-4157. (Pubitemid 46743376)
18. Marino S, Verzegnassi F, Tamaro P, et al. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response. Pediatr Blood Cancer. 2009;53: 984-991.
19. Takanashi M, Morimoto A, Yagi T, et al. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haema-tologica. 2003;88:1238-1244. (Pubitemid 37456378)
20. Chen CL, Liu Q, Pui CH, et al. Higher frequency of glutathione S-transferase deletions in black children with acute lymphoblastic leukemia. Blood. 1997;89:1701-1707. (Pubitemid 27097464)
21. Davies SM, Bhatia S, Ross JA, et al. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood. 2002;100: 67-71. (Pubitemid 35177430)
22. Krajinovic M, Labuda D, Mathonnet G, et al. Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res. 2002;8: 802-810. (Pubitemid 34742111)
23. Sala A, Lanciotti M, Valsecchi MG, et al. Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia. Leukemia. 2003;17:981-983. (Pubitemid 36626329)
24. Buchard A, Sanchez JJ, Dalhoff K, et al. Multiplex PCR detection of GSTM1, GSTT1, and GSTP1 gene variants: simultaneously detecting GSTM1 and GSTT1 gene copy number and the allelic status of the GSTP1 Ile105Val genetic variant. J Mol Diagn. 2007;9:612-617. (Pubitemid 350158420)
25. Wesolowska A, Dalgaard MD, Borst L, et al. Cost-effective multiplexing before capture allows screening of 25 000 clinically relevant SNPs in childhood acute lymphoblastic leukemia. Leukemia. 2011;25:1001-1006.
26. Gustafsson G, Schmiegelow K, Forestier E, et al. Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia. 2000;14: 2267-2275. (Pubitemid 32042267)
27. Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics. 2010;26:589-595.
28. McKenna A, Hanna M, Banks E, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297-1303.